Skip to main content
Home
Epilepsy Resource Center
FULL MENU Close Menu
Home
Home
Epilepsy Resource Center
  • Clinical Topics
  • Conference Coverage
  • Literature Monitor
  • MD-IQ
  • Patient Education
  • Epilepsy Meetings

Conference Coverage

Noninvasive testing in midlife flags late-onset epilepsy risk

Author:
Kelli Whitlock Burton
Publish date: April 27, 2023

The study could help identify at-risk individuals years before symptoms of epilepsy appear.

  • Read More

Conference Coverage

Novel neural cell therapy: A cure for focal epilepsy?

Author:
Megan Brooks
Publish date: April 24, 2023

The early significant seizure reduction observed in this study appears to be durable in these first two patients treated with a single...

  • Read More

MD IQ

Quiz: Neurobehavioral comorbidities of epilepsy

News

Thirty years of epilepsy therapy: ‘Plus ça change, plus c’est la même chose’?

Author:
Kate Johnson
Publish date: April 18, 2023

To celebrate our 30th year in print, Neurology Reviews invited experts to look back on 30 years of progress in their subspecialty. In this...

  • Read More

Literature Review

Minorities with epilepsy blocked from receiving ‘highest quality of care’

Author:
Kelli Whitlock Burton

“Increasing the attention to these inequities will, we hope, prompt changes across practices,” researchers said.

  • Read More

Literature Review

Modified Atkins diet beneficial in drug-resistant epilepsy

Author:
Kelli Whitlock Burton

Both adults and adolescents reported benefits from the diet, which is a less strict version of a traditional ketogenic diet.

  • Read More

Literature Review

Antiepileptic drugs tied to increased Parkinson’s disease risk

Author:
Batya Swift Yasgur, MA, LSW

A large case-control study found a considerably higher risk of developing Parkinson’s disease among patients who had taken AEDs in comparison with...

  • Read More

Conference Coverage

Seizures in dementia hasten decline and death

Author:
Richard Mark Kirkner
Publish date: December 14, 2022

Dementia patients who also had active seizures had shorter life expectancy and earlier decline than dementia patients who didn’t have active...

  • Read More

Conference Coverage

Three antiseizure medications join list for newborn risks

Author:
Richard Mark Kirkner
Publish date: December 13, 2022

A Scandinavian study of 4.5 million births adds carbamazepine, oxcarbazepine, and topiramate to list of antiseizure drugs linked to low birth...

  • Read More

Conference Coverage

‘Striking’ rate of mental health comorbidities in epilepsy

Author:
Pauline Anderson
Publish date: December 12, 2022

“We hope these results inspire epileptologists and neurologists to both recognize and screen ... adolescent patients.”

  • Read More

Conference Coverage

Significant racial disparities persist in status epilepticus

Author:
Pauline Anderson
Publish date: December 12, 2022

“The results suggest that racial minorities, those with a lower income, and the elderly are an appropriate target to improve health outcomes and...

  • Read More

Conference Coverage

Study implicates myelin plasticity in absence seizures

Author:
Richard Mark Kirkner
Publish date: December 9, 2022

Researchers have found that changes in the insulating layer around nerves and axons in the brain may explain the progression of absence seizures...

  • Read More

Conference Coverage

Newer brand-name drugs fuel spending on antiseizure medications

Author:
Richard Mark Kirkner

Rapid adoption of newer antiseizure medications has pushed increases in government spending that outpace the growth of prescriptions themselves....

  • Read More

News

Strong two-way link between epilepsy and depression

Author:
Megan Brooks
Publish date: December 6, 2022

The increased risks of depression following epilepsy, and vice versa, are sustained over a much more extended time period than previously shown....

  • Read More

Literature Review

High drug costs exclude most neurology patients from cutting-edge treatment

Author:
Megan Brooks

“Our study of people with neurologic conditions found that fewer than 20% were being treated with new medications.”

  • Read More

MD IQ

Quiz: Epilepsy surgery complications & outcomes

Conference Coverage

Diazepam nasal spray effective in Lennox-Gastaut syndrome

Author:
Jim Kling
Publish date: October 24, 2022

A post hoc analysis shows that the drug works about as well in Lennox-Gastaut syndrome as in patients with pediatric encephalopathies.

  • Read More

News

Shift in child hospice care is a lifeline for parents seeking a measure of comfort and hope

Author:
Bernard J. Wolfson, California Healthline
Publish date: September 22, 2022

Under a provision of the 2010 Affordable Care Act, children enrolled in Medicaid or the Children’s Health Insurance...

  • Read More

Literature Review

Drug-resistant epilepsy needs earlier surgical referral

Author:
Tara Haelle

Despite strong evidence supporting the clinical importance of surgical evaluation in patients with drug-resistant epilepsy, delays in referrals...

  • Read More

MD IQ

Quiz: Subtemporal amygdalohippocampectomy for temporal lobe epilepsy management

News

‘Striking’ jump in cost of brand-name epilepsy meds

Author:
Megan Brooks

The annual cost of brand-name ASMs rose from $2,800 in 2008 to $10,700 in 2018, while the cost of generic drugs decreased from $800 to $460 during...

  • Read More

Literature Review

Air pollution is a seizure trigger for patients with epilepsy

Author:
Pauline Anderson

“Our findings suggest that people with epilepsy should avoid high CO exposure to reduce potential seizure risk.”

  • Read More

MD IQ

Quiz: ILAE Classifications: Epilepsy etiologies

Conference Coverage

Antiseizure medication appears safe in pregnancy

Author:
Jim Kling

Verbal scores at age 3 were similar among children of mothers with or without epilepsy.

  • Read More

Conference Coverage

  • Noninvasive testing in midlife flags late-onset epilepsy risk
    Publish date: April 27, 2023
  • Novel neural cell therapy: A cure for focal epilepsy?
    Publish date: April 24, 2023
  • Seizures in dementia hasten decline and death
    Publish date: December 14, 2022
  • Three antiseizure medications join list for newborn risks
    Publish date: December 13, 2022
  • ‘Striking’ rate of mental health comorbidities in epilepsy
    Publish date: December 12, 2022
  • Significant racial disparities persist in status epilepticus
    Publish date: December 12, 2022
  • Study implicates myelin plasticity in absence seizures
    Publish date: December 9, 2022
  • Newer brand-name drugs fuel spending on antiseizure medications
  • Diazepam nasal spray effective in Lennox-Gastaut syndrome
    Publish date: October 24, 2022
  • Antiseizure medication appears safe in pregnancy
more

Multimedia

  • Patients describe significant impact of epilepsy on their lives
  • Interview with Dr. Kathryn Kvam at AAN
    Publish date: May 15, 2018
  • Tatiana Falcone, MD
    Publish date: December 18, 2017
more

Literature Review

  • Minorities with epilepsy blocked from receiving ‘highest quality of care’
  • Modified Atkins diet beneficial in drug-resistant epilepsy
  • Antiepileptic drugs tied to increased Parkinson’s disease risk
  • Strong two-way link between epilepsy and depression
    Publish date: December 6, 2022
  • High drug costs exclude most neurology patients from cutting-edge treatment
  • Drug-resistant epilepsy needs earlier surgical referral
  • ‘Striking’ jump in cost of brand-name epilepsy meds
  • Air pollution is a seizure trigger for patients with epilepsy
  • New guidance on cannabis use for treatment-resistant epilepsy
  • ILAE offers first guide to treating depression in epilepsy
more

Neurobehavioral comorbidities of epilepsy

Question 1 of 5

Among the comorbid conditions frequently associated with epilepsy is/are __________.

Anxiety disorders

Cognitive dysfunction

Depression

A and C

All of the above

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close
  • Clinical Topics
  • Conference Coverage
  • Literature Monitor
  • Literature Review
  • MD-IQ
  • Patient Education
  • Epilepsy Meetings
  • Web Resources

More

  • Neurology Reviews